|
May 27
|
The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends
|
|
May 26
|
UBS Maintains Buy Rating on Cigna (CI) Stock
|
|
May 23
|
Top Research Reports for Costco, Chubb & Cigna
|
|
May 23
|
CI's Unit Unveils Offering to Expand Access to GLP-1 Medications
|
|
May 23
|
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs
|
|
May 22
|
CMS to recover ‘uncollected overpayments’ amid Medicare audits
|
|
May 22
|
Cigna takes different approach with GLP-1s, more favorable for Eli Lilly
|
|
May 22
|
Cigna is putting a cap on weight loss drug costs
|
|
May 22
|
Wegovy and Zepbound costs capped at $200 in new Evernorth programme
|
|
May 21
|
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
|
|
May 2
|
Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength
|
|
May 2
|
Cigna (CI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 2
|
Cigna’s Earnings Come In Strong. It’s a Good Sign for Health Insurers.
|
|
May 2
|
Cigna (CI) Q1 Earnings and Revenues Surpass Estimates
|
|
May 2
|
Cigna Group Swings to Profit, Posts Higher Revenue
|
|
May 2
|
Cigna raises full-year profit forecast, latest to beat medical cost estimates
|
|
May 2
|
Cigna: Q1 Earnings Snapshot
|
|
May 2
|
Cigna (NYSE:CI) Reports Bullish Q1
|
|
May 2
|
The Cigna Group Reports Strong First Quarter 2025 Results, Raises 2025 Outlook
|
|
May 2
|
Cigna doubles down on GLP-1 support programs with 2 new launches
|